| Smiles |
[Br]C6(=CC=C(C=CC(=CC(O)C1(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C3(NC(=O)CC(O)CC(NC(=O)CCNC(C(NC(C(NC(C(NC(C(NC(C(NC(C1)=O)CO)=O)CN2(C=NC(=C2)C3))=O)CC(=O)N)=O)C(O)C(=O)N)=O)CC4(=CC=C([Br])C=C4))=O)C(=O)O))C(O)C)CO)CC5(=CC=CC=C5)))C)C=C6)
|
| CAS number |
119455-31-1
|
| Polar Surface Area |
611,88
|
| calculated LogS |
-5,391
|
| Molweight |
1651,34
|
| calculated LogP |
-7,2513
|
| H-Acceptors |
38
|
| H-Donors |
21
|
| Ro5 violations |
3
|
| Druglikeness |
-3,635
|
| DrugScore |
0,179944
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Fish Toxicity |
High FHMT
|
| Fish Toxicity2 |
1,3752
|
| Rat Acute Toxicity |
2,7166
|
| Acute Oral Toxicity |
III
|
| Caco-2 Permeability |
Caco2-
|
| Caco-2 Permeability2 |
-0,2738
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor |
Non-inhibitor
|
| P-glycoprotein Inhibitor2 |
Non-inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition2 |
Inhibitor
|
| CYP450 2C9 Substrate |
Non-substrate
|
| Tetrahymena Pyriformis Toxicity |
High TPT
|
| Tetrahymena Pyriformis Toxicity2 |
0,4635
|
| AMES Toxicity |
Non AMES toxic
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Substrate |
Non-substrate
|
| Biodegradation |
Not ready biodegradable
|
| Carcinogens |
Non-carcinogens
|
| Blood-Brain Barrier |
BBB-
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Honey Bee Toxicity |
Low HBT
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Carcinogenicity (Three-class) |
Non-required
|
| Human Intestinal Absorption |
HIA-
|
| Structure |
119455-31-1
|
